PL4162930T3 - Przygotowywanie mikro- i nanocząstek zawierających leki sposobem uderzenia strumieniowego - Google Patents

Przygotowywanie mikro- i nanocząstek zawierających leki sposobem uderzenia strumieniowego

Info

Publication number
PL4162930T3
PL4162930T3 PL21201925.1T PL21201925T PL4162930T3 PL 4162930 T3 PL4162930 T3 PL 4162930T3 PL 21201925 T PL21201925 T PL 21201925T PL 4162930 T3 PL4162930 T3 PL 4162930T3
Authority
PL
Poland
Prior art keywords
nanoparticles
drug
preparation
jet impingement
loaded micro
Prior art date
Application number
PL21201925.1T
Other languages
English (en)
Inventor
Julian VOGLER
Carsten BRÄUER
Pascale CLÉMENT
Frank Stieneker
Original Assignee
Leon-Nanodrugs Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leon-Nanodrugs Gmbh filed Critical Leon-Nanodrugs Gmbh
Publication of PL4162930T3 publication Critical patent/PL4162930T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5192Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51Nanocapsules; Nanoparticles
    • A61K9/5107Excipients; Inactive ingredients
    • A61K9/513Organic macromolecular compounds; Dendrimers
    • A61K9/5146Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153Polyesters, e.g. poly(lactide-co-glycolide)

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
PL21201925.1T 2021-10-11 2021-10-11 Przygotowywanie mikro- i nanocząstek zawierających leki sposobem uderzenia strumieniowego PL4162930T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP21201925.1A EP4162930B1 (en) 2021-10-11 2021-10-11 Preparation of drug-loaded micro- and nanoparticles by jet impingement

Publications (1)

Publication Number Publication Date
PL4162930T3 true PL4162930T3 (pl) 2025-02-24

Family

ID=78087178

Family Applications (1)

Application Number Title Priority Date Filing Date
PL21201925.1T PL4162930T3 (pl) 2021-10-11 2021-10-11 Przygotowywanie mikro- i nanocząstek zawierających leki sposobem uderzenia strumieniowego

Country Status (3)

Country Link
EP (1) EP4162930B1 (pl)
ES (1) ES2988941T3 (pl)
PL (1) PL4162930T3 (pl)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50000534D1 (de) 1999-04-08 2002-10-24 Bernd Penth Verfahren und vorrichtung zur durchführung chemischer und physikalischer prozesse
US20210030692A1 (en) * 2018-01-29 2021-02-04 The Johns Hopkins University Polymeric nanoparticle compositions for encapsulation and sustained release of protein therapeutics
AU2020343244A1 (en) * 2019-09-04 2022-04-14 The Trustees Of Princeton University Comb polymer and block copolymer stabilized nanoparticles encapsulating nucleic acids and other soluble hydrophilic compounds

Also Published As

Publication number Publication date
EP4162930B1 (en) 2024-09-25
EP4162930C0 (en) 2024-09-25
EP4162930A1 (en) 2023-04-12
ES2988941T3 (es) 2024-11-22

Similar Documents

Publication Publication Date Title
IL286424A (en) A method for the preparation of lipid-warmed RNA nanoparticles
GB2627644B (en) Method for the preparation of GalNAc-lipid nanoparticle
PY2086023A (es) Derivados de pirazolilo útiles como agentes anticancerígenos
WO2014179528A3 (en) Improve the therapeutic benefit of suboptimally administered naphthalimides
WO2017106957A8 (en) Lipid-linked prodrugs
EP3377065A4 (en) SPIROCYCLIC PYRIDOTRIAZINE DERIVATIVES FOR USE AS HIV INTEGRASE INHIBITORS
EP2931730A4 (en) 4-PYRIDINONETRIAZINE DERIVATIVES AS HIV INTEGRASE INHIBITORS
EA030189B8 (ru) Аналоги 2'-хлоронуклеозидов для инфекции вгс
MY197408A (en) 7-substituted sulfonimidoylpurinone compounds for the treatment and prophylaxis of virus infection
WO2016077464A8 (en) Amino acid derivatives and their uses
EP3389380A4 (en) SPIROCYCLIC CHINOLIZIN DERIVATIVES FOR USE AS HIV INTEGRASE INHIBITORS
MX382019B (es) Sal de un compuesto de pirimido [6,1-a]isoquinolin-4-ona.
IL305991A (en) The history of purine as anticancer agents
MX2016008087A (es) Método para producir poliamidas mediante una disposición de boquillas de rociado para la colisión de chorros de rociado.
IL271777A (en) Preparations for intravenous administration of medical substances
IL275020B1 (en) A freezing system containing nanoparticles to treat a body part of an individual in cryotherapy
GB201913262D0 (en) Positions of relase ports for sacrificial layer etching
WO2012058491A3 (en) Method for mass transfer of micro-patterns onto medical devices
GB202206060D0 (en) Acceleration of operations
WO2014177585A3 (en) Biocatalytic production of nucleoside analogues as active pharmaceutical ingredients
MX2023000439A (es) Formulaciones a largo plazo.
PL4162930T3 (pl) Przygotowywanie mikro- i nanocząstek zawierających leki sposobem uderzenia strumieniowego
GB202115335D0 (en) Surface-active agent
HUE067661T2 (hu) Procianidinek a COVID-19 által kiváltott endotheliális diszfunkció kezelésére
PT3681848T (pt) Composições para a produção de revestimentos de vidro por meio de métodos de impressão a jato de tinta e sua utilização